Skip to content

Rapid Sternal Closure System (TALON)

A Randomized, Controlled, Phase 4 Study of Sternal Plating (Rapid Sternal Closure System, KLS Martin L.P.) in Cardiac Surgical Subjects at Higher Risk for Sternal Wound Complications.

Status
Completed
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00638014
Acronym
TALON
Enrollment
51
Registered
2008-03-18
Start date
2008-03-31
Completion date
2009-07-31
Last updated
2011-05-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Mediastinitis, Sternal Wound Infection

Keywords

Sternal wound closure, cardiac surgery, sternal nonunion

Brief summary

The primary objective is to establish if the Rapid Sternal Closure System (RSCS) improves early postoperative recovery as manifested by decreased pain and improved pulmonary function. Secondary objectives include evaluation of Rapid Sternal Closure System with regard to SWCs (surgical wound complication defined as surgically treated sternal wound infection and sternal instability/non-union) as outlined in the protocol. For a given study endpoint, the null hypothesis will be no difference between the Rapid Sternal Closure System group and the control group. The alternative hypothesis will be a difference between 2 groups. The statistical objective of this study is to reject the null hypothesis in favor of the alternative hypothesis.

Interventions

DEVICERapid Sternal Closure System

Sternal talons will be used and supplemented with wires

DEVICEConventional wire closure

Conventional wire closure of sternum

Sponsors

KLS Martin, L.P.
CollaboratorUNKNOWN
Duke University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

1. Male or female. Women of childbearing potential must have a negative serum (or urine) human chorionic gonadotropin assay prior to surgery, and be willing to continue to use effective means of birth control for at least 180 days following surgery. Medically acceptable contraceptives include: (1) surgical sterilization (such as a tubal ligation or hysterectomy), (2) approved hormonal contraceptives (such as birth control pills, patches, implants or injections), (3) barrier methods (such as a condom or diaphragm) used with a spermicide, or (4) an intrauterine device (IUD). Contraceptive measures such as Plan B(TM), sold for emergency use after unprotected sex, are not acceptable methods for routine use. 2. Age ≥ 18 years. 3. Scheduled to undergo nonemergent on or off pump coronary artery bypass graft (CABG) and/or valve repair or replacement surgery through a full median sternotomy. 4. At higher risk for SWC, defined as the presence of any of the following factors: obesity (body mass index \> 30), chronic steroid use (\>6 month duration and currently using), severe chronic obstructive pulomonary disease, planned bilateral internal mammary artery harvest, undergoing redo median sternotomy, and history of radiation to the chest. 5. Willing and able to provide written informed consent. 6. Available for evaluation from baseline until final evaluation at 180 days postsurgery.

Exclusion criteria

1. Undergoing emergency cardiac surgery (urgent surgery is allowed if informed consent is obtained and the study procedures can be performed). 2. Undergoing a significant concomitant surgical procedure (eg, carotid endarterectomy, aortic root repair or replacement, deep hypothermic circulatory arrest \[DHCA\], or pulmonary resection). 3. Undergoing a minimally invasive or a thoracic surgical approach. 4. Using a preoperative mechanical assist device or intraaortic balloon pump (IABP), if inserted for shock/low output syndrome (an IABP is allowed if it is inserted for unstable angina or low ejection fraction). 5. Active and significant systemic infection, eg, active endocarditis or a history of significant recurrent systemic infection. 6. Receiving antibiotic therapy within the 2 weeks before the date of surgery. 7. History of malignancy within the past year (except for squamous or basal cell carcinoma of the skin that has been treated, with no evidence of recurrence). 8. History of major organ transplantation, including bone marrow transplantation. 9. Recent history of significant drug or alcohol abuse. 10. Current immunosuppressive condition (eg, symptomatic human immunodeficiency virus \[HIV\] infection). Use of steroids is not an

Design outcomes

Primary

MeasureTime frameDescription
Percentage Change of Preoperative Incentive Spirometry (IS) Volume AchievedBaseline, Maximum value during postoperatively days 1 thru 7Maximum incentive spirometry volume was measured at baseline (prior to surgery) and daily from postoperative day 1 through postoperative day 7 (or discharge if earlier) using a Coach 2 incentive spirometer with one way valve (Coach 2 model # 22-4000, Smiths Medical, Keene, NH).

Secondary

MeasureTime frameDescription
Number of Participants With Sternal Wound Infection or Sternal Instability/Non-unionUp to 180 daysThe Data and Safety Monitoring Board reviewed source documents for all cases with possible sternal wound infection and sternal instability or non-union and made a determination as to the presence of these complications.

Countries

United States

Participant flow

Recruitment details

Subjects were consented and enrolled in the study at 2 centers from April 2008 to July 2009.

Pre-assignment details

Overall 53 subjects were consented and enrolled in the study from April 2008 to July 2009. Two patients were not included in the analysis (1 patients' surgery was cancelled, 1 patient was not randomized due to logistical reasons), leaving a total of 51 subjects who were included in the modified intent-to-treat analysis.

Participants by arm

ArmCount
Conventional Wires Only
The control group received conventional wires including double wires to close the sternum.
23
Talon
Subjects randomized to the Talon group received Talons in the sternum plus supplementary wires in the manubrium. The number of Talons inserted was based on patient factors/clinician judgment. For study subjects randomized to the Talon, the device was to be inserted/used in an identical manner to use of the Talon in non-study patients.
28
Total51

Baseline characteristics

CharacteristicTalonConventional Wires OnlyTotal
Age, Categorical
<=18 years
0 Participants0 Participants0 Participants
Age, Categorical
>=65 years
12 Participants9 Participants21 Participants
Age, Categorical
Between 18 and 65 years
16 Participants14 Participants30 Participants
Age Continuous61.8 years
STANDARD_DEVIATION 10
63.0 years
STANDARD_DEVIATION 9.2
62.4 years
STANDARD_DEVIATION 9.6
Region of Enrollment
United States
28 participants23 participants51 participants
Sex: Female, Male
Female
4 Participants9 Participants13 Participants
Sex: Female, Male
Male
24 Participants14 Participants38 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
— / —— / —
other
Total, other adverse events
0 / 230 / 28
serious
Total, serious adverse events
1 / 231 / 28

Outcome results

Primary

Percentage Change of Preoperative Incentive Spirometry (IS) Volume Achieved

Maximum incentive spirometry volume was measured at baseline (prior to surgery) and daily from postoperative day 1 through postoperative day 7 (or discharge if earlier) using a Coach 2 incentive spirometer with one way valve (Coach 2 model # 22-4000, Smiths Medical, Keene, NH).

Time frame: Baseline, Maximum value during postoperatively days 1 thru 7

ArmMeasureValue (MEAN)Dispersion
Conventional Wires OnlyPercentage Change of Preoperative Incentive Spirometry (IS) Volume Achieved58 percentage changeStandard Deviation 24
TalonPercentage Change of Preoperative Incentive Spirometry (IS) Volume Achieved67 percentage changeStandard Deviation 32
p-value: 0.41t-test, 2 sided
Secondary

Number of Participants With Sternal Wound Infection or Sternal Instability/Non-union

The Data and Safety Monitoring Board reviewed source documents for all cases with possible sternal wound infection and sternal instability or non-union and made a determination as to the presence of these complications.

Time frame: Up to 180 days

ArmMeasureValue (NUMBER)
Conventional Wires OnlyNumber of Participants With Sternal Wound Infection or Sternal Instability/Non-union1 Participants
TalonNumber of Participants With Sternal Wound Infection or Sternal Instability/Non-union1 Participants

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026